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Purpose/Objective: Stereotactic radiotherapy (SRT) of brain 
metastasis can lead to lesion growth after varying time intervals. The 
pathophysiology of this radiation effect, that has to be distinguished 
from regrowth of the tumor, is not well understood. We made cine-
loops of serial MRI scans of patients with this effect in order to 
describe the evolution of SRT associated changes. 
Materials and Methods: Ten patients who had received SRT of brain 
metastases were selected from our departmental database. They had 
been treated on a Novalis (Brainlab, Feldkirchen, Germany). Patients 
received either single doses of 21Gy or 18Gy or three doses of 8Gy. 
Selection criteria for this study were: lesion growth after SRT not 
caused by tumor progression and the availability of at least five three-
monthly follow-up MRI scans. For the cine-loops we used post-
gadolinium 3D T1 weighted images. These MRI scans were co-
registered using iPlan 4.5 (Brainlab). From the pre-SRT MRI the axial 
slice with the largest lesion diameter was selected. For the cine-loop 
we copied the corresponding follow-up MRI images into Microsoft 
Windows Movie Maker (Microsoft Corp. Redmond USA), put them in 
chronological order and used the fading mode for the transitions 
between the separate slices. The ten MRI cine loops were interpreted 
in a joint meeting of the authors. 
Results: In all patients the cine-loops were found to be superior to the 
separate MRI’s for describing and interpreting the events after SRT. 
The sequence of events showed a similar pattern in all patients, but 
the timing of the observed events varied. In the movies we saw partial 
or complete regression of the metastasis first, followed by an 
enlarging area of contrast enhancement in the surrounding brain 
tissue. In five patients the volume of this enhancement eventually 
decreased. Histological examination of the enhancing tissue was 
possible in two patients and confirmed the existence of radiation 
necrosis without residual tumor. 
Conclusions: Cine-loop MRI analysis enabled better understanding of 
the changes that develop in follow-up MRI scans after SRT of brain 
metastases. The cine-loops showed a typical growth pattern after SRT 
with a gradually expanding area of contrast enhancement in the brain 
tissue surrounding the shrinking metastasis. 
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Purpose/Objective: To analyze the toxicity of hypofractionated lung 
SBRT according to QUANTEC recommendations.  
Materials and Methods: From 2002 to 2010, 44 (25 male, 19 female) 
patients with small primary lung cancer or oligometastasis were 
treated with several hypo-fractionation schemes of SBRT at our 
institution. All patients were immobilized using a stereotactic body 
frame, simulated with CT scan and treated with multiple static 6 MV 
beams. A total of 48 lesions were treated, among which 2 patients had 
2 lesions and 1 patient had 3 lesions. The median follow-up was 12 
months. We exported the composite dose volume histograms (DVHs) of 
gross target volume (GTV), planning target volume (PTV) and normal 
lung tissue (whole lung-GTV). For each patient, normal tissue 
complication probability (NTCP) based on the Poisson model was 
calculated using the normal lung DVH, and normalized total dose 
(NTD) volume histograms were generated at 2Gy fractions with a/b = 
3.7 Gy to account for different fractionations. Mean dose and V20 
(%volume receiving 20Gy) of GTV, PTV and normal lung derived from 
DVH/NTDVH were correlated with clinical follow-up. Variable 
importance for projection (VIP) and correlation coefficient (R) were 
calculated for each variable using partial least squares regression 
(PLSR) and logistic regression (LR) to identify the prediction factors 
for normal tissue complications. 
Results: There were 2 (4.2%) local failures, 4 (9.1%) grade 2 
pneumonitis and 3 (6.8%) radiation-induced fibrosis. The <10% 
pneumonitis rate is in line with the QUANTEC report for lung SBRT. 
5/14 (35.7%) of the lesions in right lower lobe developed 
complications, in comparison to 1/16 (6.3%) in right upper and middle 
lobes, 0/5 (0%) in left lower lobe and 1/11 (9.1%) in left upper lobe. 
The most influential VIP for predicting the complications were mean 
GTV dose (VIP =1.500, R=0.145) and GTV volume (VIP=1.451, R=-
0.140), followed by NTCP (VIP=1.106,R=0.107) although the calculated 
probability was much higher than the frequency of complications. LR 
was able to produce a reasonable NTCP curve for these three 
variables. The prediction factors used for conventional lung RT 
complications, i.e., V20, VNTD20, mean dose and mean NTD of normal 
lung had only moderate or low VIP (<0.894), were negatively 
correlated (R between -0.044 and -0.086) and could not be fit to a 
NTCP logistic curve.
Conclusions: Radiation induced complication for SBRT increases with 
the mean GTV dose and cannot be predicted with the known 
prediction factors for conventional lung RT. The cause for higher 
probability of complications for right lower lobe is unclear and needs 
further investigations. NTCP based on Poisson model might be applied 
to lung SBRT but requires different modeling parameters than that 
used for conventional lung RT. 
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Purpose/Objective: To evaluate the feasibility and efficacy of 
Stereotactic body radiation therapy (SBRT) for primary liver lesions 
and liver metastases treated with linear accelerators. 
Materials and Methods: Patients with either hepatocellular 
carcinoma, cholangiocarcinoma or metastatic liver lesions who had 
one to three lesions treated with SBRT in a single institution were 
retrospectively reviewed. Tumor response was evaluated according to 
EASL criteria 3 months after SBRT completion using MRI and/or 
abdominal CT scan. Responses were categorised as: Stable Disease 
(SD), Partial Response (PR),Complete Response (CR), Local Progression 
or Distant Progression in cases of new intra-hepatic lesions out-of-
field or extra-hepatic metastases. Local Control (LC), Progression Free 
Survival (PFS), Overall Survival (OS) and treatment-related toxicities 
are reported. 
Results: Between 2007 and 2012, 20 patients with a total of 24 lesions 
were treated with SBRT. Fourteen patients presented hepatocellular 
carcinoma (HCC), the others had either metastatic lesions from 
colorectal cancer (CRC) or cholangiocarcinoma. The median diameter 
of the lesions was 23 mm (5-98). The dose per fraction ranged from 6 
to 20 Gy with a median total dose of 60 Gy (range: 36-60 Gy). The 
dose was prescribed to the 80% isodose line covering the PTV. The 
median follow-up was 24 months. The actuarial LC rate was 78% for 
patients with HCC and 83% for those with adenocarcinoma and 
cholangiocarcinoma. Median OS was 37 months and OS rates were 88% 
at 12 and 24months. PFS was 65% and 53% at 6 and 24 months, 
respectively. Acute grade 3-4 toxicities occurred in 2 patients; a small 
proportion of the other patients experienced grade 1 or 2 toxicities. 
Conclusions: SBRT provides excellent local control with minimal side 
effects in selected patients.  
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Purpose/Objective: Describe Stereotactic Body RadioTherapy (SBRT) 
technique for treatment of this disease presentation 
Review Outcomes (Local Control, Overall Survival, and Toxicity) 
Materials and Methods: A total of 12 patients were treated with SBRT 
by the CyberKnife system between August 2009 and July 2012. All 
patients had initially presented with local/loco-regional disease. Six 
patients recurred with sternal metastases, six with Internal Mammary 
Chain (IMC) lymph node metastases. The Baseline Clinical 
Characteristics of the patients were well matched with respect to 
Age, Grade, Stage and Receptor Status at presentation. Median age at 
presentation was 45 years (Range= 30-63 years). Median Disease-Free 
Interval between presentation and relapse was 3 years (Range 1-38 
years). 2 patients that recurred in the Sternum had synchronous 
distant disease. 7 patients (58%) of the group as a whole were given 
Chemotherapy as the first treatment at the time of Sternal/IMC node 
recurrence. 10 patients (83%) had received prior conventional 
radiotherapy which overlapped with the target site.Median CTV-PTV 
